1. Phase I study of PF‐04895162, a Kv7 channel inhibitor, reveals unexpected hepatotoxicity in healthy subjects, but not rats or monkeys: clinical evidence of disrupted bile acid homeostasis. Issue 1 (11th February 2019) Authors: Aleo, Michael D.; Aubrecht, Jiri; D. Bonin, Paul; Burt, Deborah A.; Colangelo, Jennifer; Luo, Lina; Schomaker, Shelli; Swiss, Rachel; Kirby, Simon; C. Rigdon, Greg; Dua, Pinky Journal: Pharmacology research & perspectives Issue: Volume 7:Issue 1(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I study of PF‐04895162, a Kv7 channel opener, reveals unexpected hepatotoxicity in healthy subjects, but not rats or monkeys: clinical evidence of disrupted bile acid homeostasis. Issue 1 (11th February 2019) Authors: Aleo, Michael D.; Aubrecht, Jiri; D. Bonin, Paul; Burt, Deborah A.; Colangelo, Jennifer; Luo, Lina; Schomaker, Shelli; Swiss, Rachel; Kirby, Simon; C. Rigdon, Greg; Dua, Pinky Journal: Pharmacology research & perspectives Issue: Volume 7:Issue 1(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The current status of biomarkers for predicting toxicity. (November 2013) Authors: Campion, Sarah; Aubrecht, Jiri; Boekelheide, Kim; Brewster, David W; Vaidya, Vishal S; Anderson, Linnea; Burt, Deborah; Dere, Edward; Hwang, Kathleen; Pacheco, Sara; Saikumar, Janani; Schomaker, Shelli; Sigman, Mark; Goodsaid, Federico Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 9:Number 11(2013:Nov.) Page Start: 1391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗